Facebook Linkedin RSS Twitter Youtube
Home 2024

Verve Therapeutics

Top 10 Publicly Owned Gene Editing Therapy Companies
A-Lists

Top 10 Publicly Owned Gene Editing Therapy Companies

Dried Blood COVID Dx, Cryo-Shocked Tumor Cell Delivery Vehicles, Verve Halts Trial, Iambic Starts Trial, and Diagonal Therapeutics Launches
Artificial Intelligence

Dried Blood COVID Dx, Cryo-Shocked Tumor Cell Delivery Vehicles, Verve Halts Trial, Iambic Starts Trial, and Diagonal Therapeutics Launches

StockWatch: Investors Less Forgiving than Analysts as Verve Tumbles
Drug Discovery

StockWatch: Investors Less Forgiving than Analysts as Verve Tumbles

The State of Cell and Gene Therapy 2024
Artificial Intelligence

The State of Cell and Gene Therapy 2024

StockWatch: Verve Investors Accentuate the Negative as Shares Tumble, Then Recover
GEN Edge

StockWatch: Verve Investors Accentuate the Negative as Shares Tumble, Then Recover

Verve’s In Vivo Base Editing Therapy Shows Human Proof-of-Concept Data
Genome Editing

Verve’s In Vivo Base Editing Therapy Shows Human Proof-of-Concept Data

StockWatch: Lilly-Beam Deal for Verve Base Editing Therapies Wows Analysts
Drug Discovery

StockWatch: Lilly-Beam Deal for Verve Base Editing Therapies Wows Analysts

At Chardan Conference, David Liu Foresees First Prime Editing Clinical Trial in 2024
GEN Edge

At Chardan Conference, David Liu Foresees First Prime Editing Clinical Trial in 2024

Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger
Drug Discovery

Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger

FDA Places Clinical Hold on Verve’s Cardio Base Editing Therapy
Drug Discovery

FDA Places Clinical Hold on Verve’s Cardio Base Editing Therapy

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.